An in Vitro Potency Assay Using Nicotinic Acetylcholine Receptor

Total Page:16

File Type:pdf, Size:1020Kb

An in Vitro Potency Assay Using Nicotinic Acetylcholine Receptor www.nature.com/scientificreports OPEN An in vitro potency assay using nicotinic acetylcholine receptor binding works well with antivenoms Received: 12 January 2018 Accepted: 29 May 2018 against Bungarus candidus and Published: xx xx xxxx Naja naja Kavi Ratanabanangkoon1,2,3, Pavinee Simsiriwong1, Kritsada Pruksaphon4, Kae Yi Tan5, Bunkuea Chantrathonkul1, Sukanya Eursakun1 & Choo Hock Tan6 In order to facilitate/expedite the production of efective and afordable snake antivenoms, a novel in vitro potency assay was previously developed. The assay is based on an antiserum’s ability to bind to postsynaptic neurotoxin (PSNT) and thereby inhibit the PSNT binding to the nicotinic acetylcholine receptor (nAChR). The assay was shown to work well with antiserum against Thai Naja kaouthia which produces predominantly the lethal PSNTs. In this work, the assay is demonstrated to work well with antiserum/antivenom against Bungarus candidus (BC), which also produces lethal presynaptic neurotoxins, as well as antivenom against Sri Lankan Naja naja (NN), which produces an abundance of cytotoxins. The in vitro and in vivo median efective ratios (ER50s) for various batches of antisera against BC showed a correlation (R2) of 0.8922 (p < 0.001) while the corresponding value for the anti-NN antivenom was R2 = 0.7898 (p < 0.01). These results, together with the known toxin profles of various genera of elapids, suggest that this in vitro assay could be used with antisera against other species of Bungarus and Naja and possibly other neurotoxic snake venoms worldwide. The assay should signifcantly save numerous lives of mice and accelerate production of life-saving antivenoms. Snake envenomation is an important yet neglected medical problem in various developing countries with an estimated annual envenomation world wide of about 5.5 million cases1,2. Efective and afordable antivenoms (AV) which are the mainstay for treatment remain unavailable in several parts of the world while research eforts are undertaken to solve this problem3. In the development and production of an AV, an important step involves the in vivo assay to evaluate the potency of the produced antiserum/antivenom. Te standard murine lethality neutralizing assay is considered by WHO as an essential AV potency assay. Tis assay is used to fnd frst, the median lethal dose (LD50) that determines the lethality of the venom, and the median efective dose (ED50) of the AV 4,5. Te assay is expensive, laborious and, due to biological variation, ofen give highly variable results. In addition, some murine lethality results might not be consistent with the relevant efcacy outcomes in humans6,7. In Tailand, as well as in many Buddhist countries, it is very difcult to fnd researchers or students who would agree to do these in vivo experiments. Because of these reasons, various in vitro assays have been developed to reduce or replace the murine lethality assay. Te most widely used assay is based mainly on ELISA8–10 but some of these assays have ofen been shown to give poor correlation with the in vivo assay11,12. Moreover, the antigen-antibody ‘binding’ reaction of ELISA may not result in the ‘neutralization’ of the antigen, and therefore alternative in vitro assay should be developed. 1Laboratory of Immunology, Chulabhorn Research Institute, Bangkok, 10210, Thailand. 2Chulabhorn Graduate Institute, Bangkok, 10210, Thailand. 3Department of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, 10400, Thailand. 4Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. 5Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. 6Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. Correspondence and requests for materials should be addressed to K.R. (email: [email protected]) or C.H.T. (email: [email protected]) SCIENTIFIC REPORTS | (2018) 8:9716 | DOI:10.1038/s41598-018-27794-3 1 www.nature.com/scientificreports/ Figure 1. Inhibition of nAChR binding by B. candidus and N. naja venoms to NK3-coated plate. Data were means ± SD of 3 determinations. Recently, a novel in vitro assay using solubilized, purifed nicotinic acetylcholine receptor (nAChR) binding has been developed for AV potency assay against the Tai cobra Naja kaouthia13. Tis elapid snake produces mainly postsynaptic neurotoxins (PSNT) which binds specifcally and with high afnity to the nAChR at the mus- cle endplate and thereby inhibits the neuro-muscular transmission causing death in animals. Te in vitro assay therefore closely mimics the toxicological reactions in vivo; and the in vivo and in vitro potency assays showed a correlation R2 = 0.9807, p < 0.0001. Te assay should also work well with AVs against elapids in the genera other than Naja which produce mainly or exclusively post-synaptic toxins (PSNTs) e.g., King cobra, Ophiophagus hannah14. However, snakes in the genus Bungarus (kraits) also produce, in addition to PSNTs, the lethal presynaptic neurotoxins (β-neurotoxins) which in elapids, belong to the group 1 phospholipase A2 enzymes. Tese toxins do not bind to nAChR but react with receptors on the membrane of the motor nerve terminals which contain the acetylcholine vesicles. Te toxins hydrolyze the phospholipids of the plasma membrane, resulting in the loss of synaptic vesicles in the nerve terminal. Eventually the nerve terminals degenerate with the failure of the neuro- 15 16 muscular transmission . Te LD50 of the β-neurotoxins is about 10 ng/g which is considerable lower than that of the PSNT (0.18 μg/g mouse)17. It is therefore conceivable that in the case of some Bungarus venoms, death could be caused, at least in part, by the β-neurotoxins; but this efect would not be measured by the nAChR binding of the in vitro potency assay. Consequently the developed in vitro assay might not be useful for assay of AV against Bungarus spp. Another interesting case is the Naja naja (Indian cobra) which is a WHO category 1 medically most important elapid in India, Pakistan and Sri Lanka. Envenomation by this snake resulted in muscle weakness and death by respiratory failure which is likely the efect of the venom PSNTs. Interestingly, the venom of the Sri Lankan snake was shown by proteomics study to contain 71.55% of cytotoxins (cardiotoxins)18. Tese three fnger toxins (3FTs) cause severe local tissue necrosis in most (88%) of the victims18 and could possibly contribute to the venom lethal- ity. It is therefore interesting to investigate whether the developed in vitro nAChR binding assay could be used for potency assay of AV against this cobra. We report here that the in vitro nAChR binding assay, when used in the potency determinations of AVs against Bungarus candidus (Tailand) and Naja naja (Sri Lanka), gave high correlation with the corresponding in vivo murine lethality neutralization assays. Results Studies on the optimal conditions of the in vitro AV potency assay. Te optimal concentrations of NK3, nAChR, rat anti-nAChR antibody and goat-anti-rat HRP conjugate used in the assay. Te optimal con- centrations of these four reagents used in the in vitro potency assay were described in a previous study13. Te optimal concentration of NK3 for coating the plates was 15 µg/ml, and 0.707 µg/ml of nAChR for binding to the NK3 coated plate. Rat anti-nAChR serum and goat anti-rat-IgG conjugated HRP were used at 1:1600 dilution and 1:4500 dilution, respectively. Inhibition of nAChR binding to NK3-coated plate by B. candidus or N. naja venom. Crude B. candidus and N. naja venoms were separately used to determine the 50% inhibition of the nAChR binding (in vitro IC50). In the frst step, various concentrations of crude B. candidus (or N. naja) venom and the purifed nAChR (0.707 µg/ml) were incubated for 1 h at 25 °C. Afer the incubation, the solution was added to the NK3 coated plates. Te con- centration of the venom that blocked the binding of nAChR by 50% was the IC50. Te results (Fig. 1) showed that the IC50s of B. candidus and N. naja venoms were 0.1625 ± 0.0172 µg/ml and 0.4067 ± 0.0292 µg/ml, respectively. Neutralization of B. candidus or N. naja venom by horse monospecifc antisera against B. candidus or by Vins antivenom against N. naja as determined by nAChR binding to the NK3-coated plate. Nine horse monovalent anti-B. candidus sera were 2-fold diluted from 1:500 to 1:512,000. Tese diluted sera of diferent horses were separately incubated with 5xIC50 of B. candidus venom (1.4029 µg/ml) in the ‘Pre-incubation 1′ experiment. Te reaction mixtures were ultrafltered and subjected to ‘Pre-incubation 2′. Te resulting reaction mixtures were then added to the NK3-coated plates. Te nAChR binding to the plate was read at OD450nm and the results which SCIENTIFIC REPORTS | (2018) 8:9716 | DOI:10.1038/s41598-018-27794-3 2 www.nature.com/scientificreports/ Figure 2. Neutralization of B. candidus venom by horse anti-B. candidus sera (A) and neutralization of N. naja venom by Vins anti-N. naja antivenom (B) as determined by nAChR binding to NK3-coated plate. Te results were means ± SD of 3 determinations. Horse In vitro ER50 ± SD In vivo ER50 Number sera# (µg venom/µl antiserum) (mg venom/ml antiserum) 1 Bc-A 0.6698 ± 0.1091 1.19 (1.59–1.86) 2 Bc-B 0.3982 ± 0.0397 0.94 (0.62–1.46) 3 Bc-C 0.6131 ± 0.0203 1.25 (0.83–1.94) 4 Bc-D 0.6597 ± 0.0639 1.25 (0.83–1.94) 5 Bc-E 0.3184 ± 0.0690 0.75 (0.50–1.17) 6 Bc-F 0.2161 ± 0.0230 0.39 (0.26–0.60) 7 Bc-G 0.1206 ± 0.0170 0.33 (0.22–0.51) 8 Bc-H 0.0662 ± 0.0027 0.13 (0.09–0.20) 9 Bc-I 1.1083 ± 0.2009 1.50 (1.00–2.33) # Table 1.
Recommended publications
  • (Equatorial Spitting Cobra) Venom a P
    The Journal of Venomous Animals and Toxins including Tropical Diseases ISSN 1678-9199 | 2011 | volume 17 | issue 4 | pages 451-459 Biochemical and toxinological characterization of Naja sumatrana ER P (Equatorial spitting cobra) venom A P Yap MKK (1), Tan NH (1), Fung SY (1) RIGINAL O (1) Department of Molecular Medicine, Center for Natural Products and Drug Research (CENAR), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Abstract: The lethal and enzymatic activities of venom from Naja sumatrana (Equatorial spitting cobra) were determined and compared to venoms from three other Southeast Asian cobras (Naja sputatrix, Naja siamensis and Naja kaouthia). All four venoms exhibited the common characteristic enzymatic activities of Asiatic cobra venoms: low protease, phosphodiesterase, alkaline phosphomonoesterase and L-amino acid oxidase activities, moderately high acetylcholinesterase and hyaluronidase activities and high phospholipase A2. Fractionation of N. sumatrana venom by Resource® S cation exchange chromatography (GE Healthcare, USA) yielded nine major protein peaks, with all except the acidic protein peak being lethal to mice. Most of the protein peaks exhibit enzymatic activities, and L-amino acid oxidase, alkaline phosphomonoesterase, acetylcholinesterase, 5’-nucleotidase and hyaluronidase exist in multiple forms. Comparison of the Resource® S chromatograms of the four cobra venoms clearly indicates that the protein composition of N. sumatrana venom is distinct from venoms of the other two spitting cobras, N. sputatrix (Javan spitting cobra) and N. siamensis (Indochinese spitting cobra). The results support the revised systematics of the Asiatic cobra based on multivariate analysis of morphological characters. The three spitting cobra venoms exhibit two common features: the presence of basic, potentially pharmacologically active phospholipases A2 and a high content of polypeptide cardiotoxin, suggesting that the pathophysiological actions of the three spitting cobra venoms may be similar.
    [Show full text]
  • WHO Guidance on Management of Snakebites
    GUIDELINES FOR THE MANAGEMENT OF SNAKEBITES 2nd Edition GUIDELINES FOR THE MANAGEMENT OF SNAKEBITES 2nd Edition 1. 2. 3. 4. ISBN 978-92-9022- © World Health Organization 2016 2nd Edition All rights reserved. Requests for publications, or for permission to reproduce or translate WHO publications, whether for sale or for noncommercial distribution, can be obtained from Publishing and Sales, World Health Organization, Regional Office for South-East Asia, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110 002, India (fax: +91-11-23370197; e-mail: publications@ searo.who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
    [Show full text]
  • Cobra Risk Assessment
    Invasive animal risk assessment Biosecurity Queensland Agriculture Fisheries and Department of Cobra (all species) Steve Csurhes and Paul Fisher First published 2010 Updated 2016 Pest animal risk assessment © State of Queensland, 2016. The Queensland Government supports and encourages the dissemination and exchange of its information. The copyright in this publication is licensed under a Creative Commons Attribution 3.0 Australia (CC BY) licence. You must keep intact the copyright notice and attribute the State of Queensland as the source of the publication. Note: Some content in this publication may have different licence terms as indicated. For more information on this licence visit http://creativecommons.org/licenses/ by/3.0/au/deed.en" http://creativecommons.org/licenses/by/3.0/au/deed.en Photo: Image from Wikimedia Commons (this image is reproduced under the terms of a GNU Free Documentation License) Invasive animal risk assessment: Cobra 2 Contents Summary 4 Introduction 5 Identity and taxonomy 5 Taxonomy 3 Description 5 Diet 5 Reproduction 6 Predators and diseases 6 Origin and distribution 7 Status in Australia and Queensland 8 Preferred habitat 9 History as a pest elsewhere 9 Uses 9 Pest potential in Queensland 10 Climate match 10 Habitat suitability 10 Broad natural geographic range 11 Generalist diet 11 Venom production 11 Disease 11 Numerical risk analysis 11 References 12 Attachment 1 13 Invasive animal risk assessment: Cobra 3 Summary The common name ‘cobra’ applies to 30 species in 7 genera within the family Elapidae, all of which can produce a hood when threatened. All cobra species are venomous. As a group, cobras have an extensive distribution over large parts of Africa, Asia, Malaysia and Indonesia.
    [Show full text]
  • Fibrinogenolytic Toxin from Indian Monocled Cobra (Naja Kaouthia) Venom
    Fibrinogenolytic toxin from Indian monocled cobra (Naja kaouthia) venom CCHANDRA SEKHAR and DIBAKAR CHAKRABARTY* Department of Biological Sciences, Birla Institute of Technology and Science–Pilani, KK Birla Goa Campus, Zuarinagar, Goa 403 726, India *Corresponding author (Fax, +91-832-255-7033; Email, [email protected], [email protected]) A fibrinogenolytic toxin of molecular weight 6.5 kDa has been purified from the venom of Indian monocled cobra (Naja kaouthia) by repeated cation exchange chromatography on CM-sephadex C-50. The purified toxin did not show any phospholipase activity but was mildly hemolytic on human erythrocytes. This toxin, called Lahirin, cleaved fibrinogen in a dose- and time-dependent manner. The digestion process apparently started with the Aα chain, and gradually other lower-molecular-weight chains were also cleaved to low-molecular-weight peptides. The fibrinolytic activity was completely lost after treatment with ethylene di-amine tetra acetic acid (EDTA). However, exposure to 100°C for 1 min or pre-treatment with phenyl methyl sulfonyl fluoride (PMSF) did not affect the fibrinolytic activity. Cleavage of di-sulphide bonds by β-mercaptoethanol or unfolding the protein with 4 M urea caused complete loss of activity of pure Lahirin. [Chandra Sekhar C and Chakrabarty D 2011 Fibrinogenolytic toxin from Indian monocled cobra (Naja kaouthia) venom. J. Biosci. 36 355–361] DOI 10.1007/s12038-011-9068-3 1. Introduction venom. However, in the course of the present study, these authors came across several anticoagulant/fibrinogenolytic Monocled and spectacled cobras are the most frequently factors of wide-ranging molecular weights (MWs) in mono- encountered venomous snakes in India.
    [Show full text]
  • Quantitative Characterization of the Hemorrhagic, Necrotic, Coagulation
    Hindawi Journal of Toxicology Volume 2018, Article ID 6940798, 8 pages https://doi.org/10.1155/2018/6940798 Research Article Quantitative Characterization of the Hemorrhagic, Necrotic, Coagulation-Altering Properties and Edema-Forming Effects of Zebra Snake (Naja nigricincta nigricincta)Venom Erick Kandiwa,1 Borden Mushonga,1 Alaster Samkange ,1 and Ezequiel Fabiano2 1 School of Veterinary Medicine, Faculty of Agriculture and Natural Resources, Neudamm Campus, University of Namibia, P. Bag 13301, Pioneers Park, Windhoek, Namibia 2Department of Wildlife Management and Ecotourism, Katima Mulilo Campus, Faculty of Agriculture and Natural Resources, University of Namibia, P. Bag 1096, Ngweze, Katima Mulilo, Namibia Correspondence should be addressed to Alaster Samkange; [email protected] Received 30 May 2018; Revised 5 October 2018; Accepted 10 October 2018; Published 24 October 2018 Academic Editor: Anthony DeCaprio Copyright © 2018 Erick Kandiwa et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Tis study was designed to investigate the cytotoxicity and haemotoxicity of the Western barred (zebra) spitting cobra (Naja nigricincta nigricincta) venom to help explain atypical and inconsistent reports on syndromes by Namibian physicians treating victims of human ophidian accidents. Freeze-dried venom milked from adult zebra snakes was dissolved in phosphate bufered saline (PBS) for use in this study. Haemorrhagic and necrotic activity of venom were studied in New Zealand albino rabbits. Oedema-forming activity was investigated in 10-day-old Cobb500 broiler chicks. Procoagulant and thrombolytic activity was investigated in adult Kalahari red goat blood in vitro.
    [Show full text]
  • Subgenus: Naja, Afronaja, Boulengerina and Uraeus)
    Toxins 2019, 11, 116; doi: 10.3390/toxins11020116 www.mdpi.com/journal/toxins S1 of S2 Supplementary Materials: Distribution of Secretory Phospholipases A2 in the Venoms of Afro-Asian Cobras (Subgenus: Naja, Afronaja, Boulengerina and Uraeus) Choo Hock Tan, Kin Ying Wong, Nget Hong Tan, Tzu Shan Ng and Kae Yi Tan Figure 1. Time-dependent pH changes in acidimetric assay for the venoms of four subgenera of cobra. (A) Naja, (B) Afronaja, (C) Boulengerina, and (D) Uraeus. Hydrolysis of phospholipids by phospholipase A2 released fatty acids that reduced the suspension pH time-dependently. Toxins 2019, 11, 116; doi: 10.3390/toxins11020116 www.mdpi.com/journal/toxins S2 of S2 Figure S2. Time-dependent absorbance changes in colorimetric assay for the venoms of four subgenera of cobra. (A) Naja, (B) Afronaja, (C) Boulengerina, and (D) Uraeus. Changes in absorbance were due to the hydrolysis of the synthetic chromogenic substrate (NOBA), corresponding to the enzymatic activity of phospholipases A2 in the venoms. Toxins 2019, 11, 116; doi: 10.3390/toxins11020116 www.mdpi.com/journal/toxins S3 of S2 Table S1. Relative abundances of snake venom phospholipase A2 of 12 cobra species (Genus: Naja). Relative Subgenus Cobra Source Abundance of Method of Protein Identification References of Naja Species PLA2 (%) Bottom up proteomic: RP-HPLC, in-gel digestion, MALDI TOF/TOF and nano-ESI-LCMS/MS Naja naja Latoxan (Pakistan) 14.24 [1] Abundance calculation: gel densitometry x peak area under curve of chromatographic fraction Bottom up proteomic: RP-HPLC, in-gel
    [Show full text]
  • Snake Venomics of Monocled Cobra (Naja Kaouthia) and Investigation of Human Igg Response Against Venom Toxins
    Downloaded from orbit.dtu.dk on: May 08, 2019 Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins Laustsen, Andreas Hougaard; Gutiérrez, José María; Lohse, Brian; Rasmussen, Arne R.; Fernández, Julián; Milbo, Christina; Lomonte, Bruno Published in: Toxicon Link to article, DOI: 10.1016/j.toxicon.2015.03.001 Publication date: 2015 Document Version Peer reviewed version Link back to DTU Orbit Citation (APA): Laustsen, A. H., Gutiérrez, J. M., Lohse, B., Rasmussen, A. R., Fernández, J., Milbo, C., & Lomonte, B. (2015). Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins. Toxicon, 99, 23-35. https://doi.org/10.1016/j.toxicon.2015.03.001 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. *Manuscript Click here to view linked References 1 2 Snake venomics of monocled cobra (Naja kaouthia) and 3 investigation of human IgG response against venom toxins 4 5 Andreas H.
    [Show full text]
  • A Pan-Specific Antiserum Produced by a Novel Immunization Strategy
    www.nature.com/scientificreports OPEN A pan-specifc antiserum produced by a novel immunization strategy shows a high spectrum of neutralization against neurotoxic snake venoms Kavi Ratanabanangkoon1,2 ✉ , Kae Yi Tan3, Kritsada Pruksaphon4, Chaiya Klinpayom5, José María Gutiérrez6, Naeem H. Quraishi7 & Choo Hock Tan8 ✉ Snakebite envenomation is a neglected tropical disease of high mortality and morbidity largely due to insufcient supply of efective and afordable antivenoms. Snake antivenoms are mostly efective against the venoms used in their production. It is thus crucial that efective and afordable antivenom(s) with wide para-specifcity, capable of neutralizing the venoms of a large number of snakes, be produced. Here we studied the pan-specifc antiserum prepared previously by a novel immunization strategy involving the exposure of horses to a ‘diverse toxin repertoire’ consisting of 12 neurotoxic Asian snake toxin fractions/ venoms from six species. This antiserum was previously shown to exhibit wide para-specifcity by neutralizing 11 homologous and 16 heterologous venoms from Asia and Africa. We now show that the antiserum can neutralize 9 out of 10 additional neurotoxic venoms. Altogether, 36 snake venoms belonging to 10 genera from 4 continents were neutralized by the antiserum. Toxin profles previously generated using proteomic techniques of these 36 venoms identifed α-neurotoxins, β-neurotoxins, and cytotoxins as predominant toxins presumably neutralized by the antiserum. The bases for the wide para-specifcity of the antiserum are discussed. These fndings indicate that it is feasible to generate antivenoms of wide para-specifcity against elapid neurotoxic venoms from diferent regions in the world and raises the possibility of a universal neurotoxic antivenom.
    [Show full text]
  • Snake Venomics of Monocled Cobra (Naja Kaouthia) and Investigation of Human Igg Response Against Venom Toxins
    Downloaded from orbit.dtu.dk on: Sep 27, 2021 Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins Laustsen, Andreas Hougaard; Gutiérrez, José María; Lohse, Brian; Rasmussen, Arne R.; Fernández, Julián; Milbo, Christina; Lomonte, Bruno Published in: Toxicon Link to article, DOI: 10.1016/j.toxicon.2015.03.001 Publication date: 2015 Document Version Peer reviewed version Link back to DTU Orbit Citation (APA): Laustsen, A. H., Gutiérrez, J. M., Lohse, B., Rasmussen, A. R., Fernández, J., Milbo, C., & Lomonte, B. (2015). Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins. Toxicon, 99, 23-35. https://doi.org/10.1016/j.toxicon.2015.03.001 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. *Manuscript Click here to view linked References 1 2 Snake venomics of monocled cobra (Naja kaouthia) and 3 investigation of human IgG response against venom toxins 4 5 Andreas H.
    [Show full text]
  • A POTENTIAL ANTICANCER AGENT Panda Subhamay*1, 2, Kumari Leena3, Panda Santamay2, 4 1Department of Pharmacy, Gupta College of Technological Sciences, Ashram More, G.T
    Panda et al Journal of Drug Delivery & Therapeutics. 2016; 6(3):59-63 59 Available online on 15.05.2016 at http://jddtonline.info Journal of Drug Delivery and Therapeutics An International Peer Reviewed Journal Open access to Pharmaceutical and Medical research © 2016, publisher and licensee JDDT, This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited RESEARCH ARTICLE STRUCTURAL UNDERSTANDING OF CYTOTOXIN 1 OF NAJA SPUTATRIX: A POTENTIAL ANTICANCER AGENT Panda Subhamay*1, 2, Kumari Leena3, Panda Santamay2, 4 1Department of Pharmacy, Gupta College of Technological Sciences, Ashram More, G.T. Road, Asansol-713301 2Indian Institute of Human and Social Sciences, Sitarampur, Asansol-713359 3Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India 4Department of Physics, NSHM Faculty of Engineering & Technology, NSHM Knowledge Campus, Durgapur-713212 * Corresponding author: E-mail: [email protected] Received 16 March 2016; Review Completed 22 April 2016; Accepted 27 April 2016, Available online 15 May 2016 ABSTRACT: Snake venom cytotoxin from different Naja species possesses significant cytotoxic activity on tumor cells. The cytoxin from snake venom can exert a plethora of biological activities including depolarization and muscular cell contraction, lysis of variety of cells such as red blood cells, epithelial cells and fetal lung cells, and also apoptotic activity on certain types of tumor cells. In the present article, we have effectively utilized comparative modeling approach to propose the first molecular model structure of cytotoxin 1 of Naja sputatrix. The charge distribution on the structure and distribution of secondary structural elements were also investigated with the aid of In silico based approach.
    [Show full text]
  • Report of the Presence of Wild Animals
    Report of the Presence of Wild Animals The information recorded here is essential to emergency services personnel so that they may protect themselves and your neighbors, provide for the safety of your animals, ensure the maximum protection and preservation of your property, and provide you with emergency services without unnecessary delay. Every person in New York State, who owns, possesses, or harbors a wild animal, as set forth in General Municipal Law §209-cc, must file this Report annually, on or before April 1, of each year, with the clerk of the city, village or town (if outside a village) where the animal is kept. A list of the common names of animals to be reported is enclosed with this form. Failure to file as required will subject you to penalties under law. A separate Report is required to be filed annually for each address where a wild animal is harbored. Exemptions: Pet dealers, as defined in section 752-a of the General Business Law, zoological facilities and other exhibitors licensed pursuant to U.S. Code Title 7 Chapter 54 Sections 2132, 2133 and 2134, and licensed veterinarians in temporary possession of dangerous dogs, are not required to file this report. Instructions for completing this form: 1. Please print or type all information, using blue or black ink. 2. Fill in the information requested on this page. 3. On the continuation sheets, fill in the information requested for each type of animal that you possess. 4. Return the completed forms to the city, town, or village clerk of each municipality where the animal or animals are owned, possessed or harbored.
    [Show full text]
  • Biolphilately Vol-64 No-3
    148 Biophilately September 2017 Vol. 66 (3) THE WORLD’S 20 MOST VENOMOUS SNAKES Jack R. Congrove, BU1424 [Ed. Note: Much of this information was taken from an on-line listing at LiveOutdoors.com. It is interesting that the top three most venomous snakes and five of the top 20 are all from Australia. Actually when you study Australian fauna, you will find that almost every creature living there will kill you if you give it a chance. It is also interesting that only one species on the list is endemic to North America and that one lives in southern Mexico and Central America.] Inland Taipan Considered the most venomous snake in the world based on the median lethal dose value in mice, the Inland Taipan (Oxyuranus microlepidotus) venom, drop by drop, is by far the most toxic of any snake. One bite has enough lethality to kill at least 100 full grown men. Found in the semi-arid regions of central east Australia, it is commonly known as the Western Taipan, Small-scaled Snake, or the Fierce Snake. Like every Australian snake, the Inland Taipan is protected by law. Eastern Brown Snake The Eastern Brown Snake (Pseudonaja textilis), or the Common Brown Snake, is considered the second most venomous snake in Oxyuranus microlepidotus the world. It is native to Australia, Papua New Guinea, and Austria, 2016, n/a Indonesia. It can be aggressive and is responsible for about 60 percent of snake bite deaths in Australia. Coastal Taipan The Coastal Taipan (Oxyuranus scutellatus) is a venomous snake found in northern and eastern Australia and the island of New Guinea.
    [Show full text]